DTL
ARRY

Dynamic Technology Lab’s Array Biopharma Inc ARRY Stock Holding History

Dynamic Technology Lab’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-48,058
Closed -$685K – 1482
2018
Q4 		$685K Buy
+48,058
New +$729K 0.12% 280
2017
Q3 		– Sell
-44,385
Closed -$372K – 1521
2017
Q2 		$372K Buy
44,385
+10,546
+31% +$86.2K 0.07% 572
2017
Q1 		$303K Buy
+33,839
New +$360K 0.07% 570
2016
Q1 		– Sell
-23,609
Closed -$100K – 1299
2015
Q4 		$100K Buy
23,609
+7,633
+48% +$34.8K 0.03% 807
2015
Q3 		$73K Buy
+15,976
New +$94.7K 0.02% 758
2014
Q3 		– Sell
-16,933
Closed -$77K – 948
2014
Q2 		$77K Buy
+16,933
New +$70K 0.04% 615
2014
Q1 		– Sell
-26,410
Closed -$132K – 801
2013
Q4 		$132K Buy
+26,410
New +$144K 0.09% 444

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Dynamic Technology Lab's ARRY Position: Q1 2019 in Review

Dynamic Technology Lab sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 48,058 shares — an estimated $685K sold.

Dynamic Technology Lab first reported a position in ARRY in Q4 2013 and held it in 7 quarters. The position peaked at $685K in Q4 2018. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • Dynamic Technology Lab reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • Dynamic Technology Lab sold 48,058 Array Biopharma Inc shares in Q1 2019, an estimated $685K.
  • Dynamic Technology Lab first reported a position in Array Biopharma Inc in Q4 2013 and held it in 7 quarters.
  • Dynamic Technology Lab's Array Biopharma Inc position peaked at $685K in Q4 2018.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Dynamic Technology Lab's 13F filing for Q1 2019, filed 13 May 2019.